The histamine H3 receptor (H3R) is primarily involved in the presynaptic inhibitory regulation of neurotransmitter release in the central nervous system (CNS) and is consequently considered as potential therapeutic target for various neurological and psychiatric diseases [7,8,9]. The gene discussed is HRH3; the disease is psychiatric disorder.